Cargando…

Chemotherapy for Elderly Ovarian Cancer Patients

OBJECTIVE: Ovarian cancer is the most lethal cancer involving the female pelvic reproductive system. Its incidence increases with age and with an aging population, its prevalence should also increase. The goal of our retrospective study is to report our experience in treating women over 65 years of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muralikrishnan, Sivraj, Hatzis, Christos, Katz, Andrea, Santin, Alessandro, Schwartz, Peter E, Abu-Khalaf, Maysa M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042145/ https://www.ncbi.nlm.nih.gov/pubmed/27695647 http://dx.doi.org/10.4172/2161-0932.1000397

Ejemplares similares

Binimetinib (MEK162) in recurrent low-grade serous ovarian cancer resistant to chemotherapy and hormonal treatment
por: Han, Chanhee, et al.
Publicado: (2018)

Treatment Considerations for Patients with Unresectable Metastatic Melanoma Who Develop Pembrolizumab-Induced Guillain-Barré Toxicity: A Case Report
por: Muralikrishnan, Sivraj, et al.
Publicado: (2020)

Chemotherapy of ovarian cancer in elderly patients
por: Troso-Sandoval, Tiffany A., et al.
Publicado: (2015)

Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer
por: Sanft, Tara, et al.
Publicado: (2015)

Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer
por: Cocco, Emiliano, et al.
Publicado: (2010)

Cancer Therapy Related Cardiotoxicity
por: Abu-Khalaf, Maysa M, et al.
Publicado: (2011)

Pembrolizumab and lenvatinib in recurrent ovarian clear cell carcinoma resistant to chemotherapy
por: McNamara, Blair, et al.
Publicado: (2023)

Regression of metastatic, radiation/chemotherapy-resistant uterine serous carcinoma overexpressing HER2/neu with trastuzumab emtansine (TDM-1)
por: Santin, Alessandro D., et al.
Publicado: (2016)

Mutation based treatment recommendations from next generation sequencing data: a comparison of web tools
por: Patel, Jaymin M., et al.
Publicado: (2016)

AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers
por: Abu-Khalaf, Maysa M., et al.
Publicado: (2023)

Clinical outcomes of chemotherapy in cancer patients with different ethnicities
por: Pathak, Suhrud, et al.
Publicado: (2023)

Functional polymorphisms in cancer
por: Agarwal, Divyansh, et al.
Publicado: (2015)

Quantitative measurements of HER2 and phospho-HER2 expression: correlation with pathologic response to neoadjuvant chemotherapy and trastuzumab
por: Cheng, Huan, et al.
Publicado: (2014)

Chemotherapy in Elderly Patients with Gastric Cancer
por: Kim, Hyeong Su, et al.
Publicado: (2016)

Claudins Overexpression in Ovarian Cancer: Potential Targets for Clostridium Perfringens Enterotoxin (CPE) Based Diagnosis and Therapy
por: English, Diana P., et al.
Publicado: (2013)

Adherence to the Mediterranean Diet in Relation to Obesity Indices before and after a Weight Reduction Program in OSAS Patients
por: PAPANDREOU, Christopher, et al.
Publicado: (2014)

Adjuvant chemotherapy in elderly patients with pancreatic cancer
por: Nagrial, A M, et al.
Publicado: (2014)

Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival
por: Wright, J D, et al.
Publicado: (2008)

Chemotherapy Resistance in Advanced Ovarian Cancer Patients
por: Pokhriyal, Ruchika, et al.
Publicado: (2019)

Biological Insights into Chemotherapy Resistance in Ovarian Cancer
por: Glasgow, Michelle A., et al.
Publicado: (2019)

Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients
por: Glimelius, Bengt, et al.
Publicado: (2020)

Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer
por: Jewell, Andrea, et al.
Publicado: (2018)

Microtubule-Interfering Drugs: Current and Future Roles in Epithelial Ovarian Cancer Treatment
por: Tymon-Rosario, Joan, et al.
Publicado: (2021)

A KRAS-variant is a Biomarker of Poor Outcome, Platinum Chemotherapy Resistance and a Potential Target for Therapy in Ovarian Cancer
por: Ratner, Elena S., et al.
Publicado: (2011)

Chemotherapy for ovarian cancer--trials, controversies and funding.
por: Hawkins, R. E.
Publicado: (1998)

FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients
por: Tassi, Renata A., et al.
Publicado: (2017)

High-dose-rate vaginal brachytherapy with chemotherapy for surgically staged localized uterine serous carcinoma
por: Damast, Shari, et al.
Publicado: (2015)

Genomic and Immune Profiling of a Patient With Triple-Negative Breast Cancer That Progressed During Neoadjuvant Chemotherapy Plus PD-L1 Blockade
por: Casadevall, David, et al.
Publicado: (2019)

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
por: Riggs, McKayla J., et al.
Publicado: (2020)

Mechanisms of chemotherapy resistance in ovarian cancer
por: Ortiz, Mylena, et al.
Publicado: (2022)

Common Contaminants in Next-Generation Sequencing That Hinder Discovery of Low-Abundance Microbes
por: Laurence, Martin, et al.
Publicado: (2014)

Preference of elderly patients’ to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial
por: Chekerov, Radoslav, et al.
Publicado: (2017)

Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
por: Perroud, Herman Andrés, et al.
Publicado: (2017)

Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19
por: Liontos, Michalis, et al.
Publicado: (2020)

Comparative Effectiveness of Chemotherapy in Elderly Patients with Metastatic Colorectal Cancer
por: Satram-Hoang, Sacha, et al.
Publicado: (2012)

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer
por: Saif, Muhammad Wasif
Publicado: (2012)

Prevalence of Geriatric Syndromes in Elderly Cancer Patients Receiving Chemotherapy
por: Limpawattana, Panita, et al.
Publicado: (2020)

Efficacy and Safety of Chemotherapy in Elderly Patients with Unresectable Pancreatic Cancer
por: Kwan, Byung Soo, et al.
Publicado: (2023)

Safety and Effectiveness of Chemotherapy in Elderly Biliary Tract Cancer Patients
por: Okamoto, Takeshi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dtflblj41haea8d4u2ch6slqq2